Home » Newsletters » BioWorld

BioWorld

Sep. 22, 1997

View Archived Issues

Slowdown In US Start-Ups Balanced By European Surge

Alpha-Beta Lays Off 60 To Focus On Betafectin

Avigen's Third-Generation Gene Therapy Employing Viral Proteins, Not Viruses

Genentech Says Phase II Data Positive For Asthma Drug

A Message To BioWorld Subscribers About Copyright Law

Other News To Note

Chiron Agrees To Pay $50M In Deal With Australian Firm For Hepatitis C Treatment